Schedule of investment in associates (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Investment In Associates | ||
| Unquoted shares - at cost beginning | $ 1,493,850 | $ 1,493,850 |
| Disposal during the financial year | (677) | |
| Reclassification to Other Investment during the financial year (Note 8) | (1,492,955) | |
| Unquoted shares- at cost end | 218 | 1,493,850 |
| Accumulated impairment loss beginning | (257) | (257) |
| Reversal of impairment during the financial year | 263 | |
| Exchange difference | (6) | |
| Accumulated impairment loss ending | (257) | |
| Unquoted shares- at cost, net | 218 | 1,493,593 |
| Share of post-acquisition reserve beginning | 3,151 | 13,911 |
| Share profit((loss) during the financial year | 14,449 | (10,760) |
| Share of post-acquisition reserve ending | 17,600 | 3,151 |
| Share of post- acquisition reserve, net | 17,818 | 1,496,744 |
| Exchange differences | 788 | 99,432 |
| Investment in associates | $ 18,606 | $ 1,596,176 |